Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (300357) — Capital Reinvestment Ratio
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (300357) has a Capital Reinvestment Ratio of 0.26x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥88.11 Million) in capital expenditures (CN¥22.77 Million). See 300357 equity to assets ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd Capital Reinvestment Ratio (2009–2024)
This chart tracks Zhejiang Wolwo Bio-Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 16 annual periods. Check 300357 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (2009–2024)
Year-by-year Capital Reinvestment Ratio for Zhejiang Wolwo Bio-Pharmaceutical Co Ltd from 2009 to 2024. For live market cap and broader valuation context, see 300357 market cap.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.45x | CN¥262.44 Million | CN¥117.97 Million | ▼ -16.5% |
| 2023 | 0.54x | CN¥388.32 Million | CN¥209.16 Million | ▲ +2.8% |
| 2022 | 0.52x | CN¥360.28 Million | CN¥188.74 Million | ▲ +54.6% |
| 2021 | 0.34x | CN¥360.58 Million | CN¥122.16 Million | ▲ +23.7% |
| 2020 | 0.27x | CN¥256.22 Million | CN¥70.16 Million | ▼ -36.1% |
| 2019 | 0.43x | CN¥232.93 Million | CN¥99.83 Million | ▲ +53.2% |
| 2018 | 0.28x | CN¥206.45 Million | CN¥57.75 Million | ▲ +28.2% |
| 2017 | 0.22x | CN¥159.13 Million | CN¥34.73 Million | ▼ -25.4% |
| 2016 | 0.29x | CN¥122.77 Million | CN¥35.93 Million | ▲ +6.6% |
| 2015 | 0.27x | CN¥114.82 Million | CN¥31.51 Million | ▲ +1.3% |
| 2014 | 0.27x | CN¥83.70 Million | CN¥22.67 Million | ▼ -9.9% |
| 2013 | 0.30x | CN¥58.30 Million | CN¥17.53 Million | ▲ +70.8% |
| 2012 | 0.18x | CN¥41.17 Million | CN¥7.25 Million | ▼ -15.6% |
| 2011 | 0.21x | CN¥19.15 Million | CN¥3.99 Million | ▼ -71.3% |
| 2010 | 0.73x | CN¥14.54 Million | CN¥10.56 Million | ▼ -57.3% |
| 2009 | 1.70x | CN¥12.63 Million | CN¥21.48 Million | — |